Filing Details
- Accession Number:
- 0001883850-22-000102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-02 16:05:43
- Reporting Period:
- 2022-12-01
- Accepted Time:
- 2022-12-02 16:05:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-01 | 2,500 | $381.92 | 31,244 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-01 | 1,890 | $760.35 | 29,354 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-12-02 | 582 | $756.50 | 28,772 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-12-02 | 16 | $759.90 | 28,756 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-12-02 | 12 | $760.19 | 28,744 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-12-01 | 2,500 | $0.00 | 2,500 | $381.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,800 | 2026-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 250 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
